Company

Nuuron GmbH

Nuuron develops a digital therapy using visual stimuli to treat Alzheimer's disease.

About

Nuuron develops Memory Pacemaker, a digital therapy intended to treat Alzheimer's disease using VR and AR technologies to deliver stimuli through the retina. The company was founded in 2023 by Fabian Queisner and Markus Müschenich and is based in Berlin, Germany. In October 2024, it raised EUR 3.5 million in seed funding led by High-Tech Gründerfonds, with participation from IBB Ventures, Caesar Ventures and Business Angels Club Berlin-Brandenburg. The funding will support clinical studies.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in